AU2003217392A8 - Methods for identifying targeting domains and methods and compositions comprising the same - Google Patents
Methods for identifying targeting domains and methods and compositions comprising the sameInfo
- Publication number
- AU2003217392A8 AU2003217392A8 AU2003217392A AU2003217392A AU2003217392A8 AU 2003217392 A8 AU2003217392 A8 AU 2003217392A8 AU 2003217392 A AU2003217392 A AU 2003217392A AU 2003217392 A AU2003217392 A AU 2003217392A AU 2003217392 A8 AU2003217392 A8 AU 2003217392A8
- Authority
- AU
- Australia
- Prior art keywords
- methods
- compositions
- same
- targeting domains
- identifying targeting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5082—Supracellular entities, e.g. tissue, organisms
- G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Microbiology (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35452002P | 2002-02-08 | 2002-02-08 | |
US60/354,520 | 2002-02-08 | ||
PCT/US2003/004280 WO2003066639A2 (en) | 2002-02-08 | 2003-02-10 | Methods for identifying targeting domains and methods and compositions comprising the same |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003217392A8 true AU2003217392A8 (en) | 2003-09-02 |
AU2003217392A1 AU2003217392A1 (en) | 2003-09-02 |
Family
ID=27734387
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003217392A Abandoned AU2003217392A1 (en) | 2002-02-08 | 2003-02-10 | Methods for identifying targeting domains and methods and compositions comprising the same |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003217392A1 (en) |
WO (1) | WO2003066639A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8124052B2 (en) | 2003-02-10 | 2012-02-28 | Georgetown University | Method for identifying targeting domains and methods and compositions comprising the same |
WO2003066639A2 (en) * | 2002-02-08 | 2003-08-14 | Georgetown University Medical Center | Methods for identifying targeting domains and methods and compositions comprising the same |
WO2006108094A2 (en) * | 2005-04-05 | 2006-10-12 | Georgetown University | Organ homing genes of cancer metastases |
CN113286564A (en) * | 2018-08-02 | 2021-08-20 | 乔治敦大学 | Methods and compositions for cell transplantation |
CN109270905B (en) * | 2018-10-22 | 2019-11-29 | 山东大学 | A kind of method that group robot neural network based is looked for food using pheromones communication realization cooperation |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003066639A2 (en) * | 2002-02-08 | 2003-08-14 | Georgetown University Medical Center | Methods for identifying targeting domains and methods and compositions comprising the same |
-
2003
- 2003-02-10 WO PCT/US2003/004280 patent/WO2003066639A2/en not_active Application Discontinuation
- 2003-02-10 AU AU2003217392A patent/AU2003217392A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2003066639A3 (en) | 2004-11-04 |
AU2003217392A1 (en) | 2003-09-02 |
WO2003066639A2 (en) | 2003-08-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2089A (en) | Compositions and methods for combination antiviraltherapy | |
IL164021A0 (en) | Antibodies and anti-pharmaceutical compositions containing the same | |
AU2002357119A8 (en) | Mitocidal compositions and methods | |
GB0411940D0 (en) | Methods and compositions | |
AU2003220205A8 (en) | Ethanol-diesel fuel composition and methods thereof | |
EP1701725A4 (en) | Methods and compositions | |
EP1679966A4 (en) | Substituted benzimidazole-, benztriazole-, and benzimidazolone-o-glucosides | |
EP1633718A4 (en) | COMPOSITIONS AND METHODS FOR INHIBITING TGF-s | |
EG24579A (en) | Herbicide composition and weed-controlling method using the same | |
PL1651042T3 (en) | Herbicidal composition having the herbicidal effect enhanced, and method for enhancing the herbicidal effect | |
EP1537089A4 (en) | Compounds compositions and methods | |
AU2003275268A8 (en) | Hemostatic compositions and methods | |
EP1684771A4 (en) | Composition and method | |
SI1551805T1 (en) | Substituted gamma-phenyl-delta-lactams and uses related thereto | |
EP1455841A4 (en) | Osteopontin-related compositions and methods | |
AU2003240281A8 (en) | Cell targeting methods and compositions | |
AU2003217392A8 (en) | Methods for identifying targeting domains and methods and compositions comprising the same | |
AU2002366809A8 (en) | Syn3 compositions and methods | |
GB0124860D0 (en) | Composition and media | |
GB0202187D0 (en) | "Inhibitors" | |
AU2003245524A8 (en) | Cryosurgery compositions and methods | |
GB0207224D0 (en) | Tenascin-W compositions and uses thereof | |
AU2002359869A8 (en) | Pak5-related compositions and methods | |
AU2003297297A8 (en) | Elf3 gene compositions and methods | |
AU2003247397A8 (en) | Common ligand universal enzyme and compositions for use therein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |